Revenues of Exousia Bio, Inc. from 31 May 2022 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Exousia Bio, Inc. quarterly and annual Revenues in USD history and change rate from 31 May 2022 to 30 Nov 2025.
  • Exousia Bio, Inc. Revenues for the quarter ending 30 Nov 2025 was $0.
  • Exousia Bio, Inc. Revenues for the twelve months ending 30 Nov 2025 was $0, a 100% decline year-over-year.
  • Exousia Bio, Inc. annual Revenues for 2024 was $3,750, a 67% decline from 2023.
  • Exousia Bio, Inc. annual Revenues for 2023 was $11,500.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Exousia Bio, Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 $0 $0 01 Sep 2025 30 Nov 2025 10-Q 17 Mar 2026 2026 Q2
Q3 2025 $0 $0 -$3,750 -100% 01 Jun 2025 31 Aug 2025 10-Q 17 Nov 2025 2026 Q1
Q2 2025 $3,750 $0 -$3,750 -100% 01 Mar 2025 31 May 2025 10-K 17 Oct 2025 2025 FY
Q1 2025 $7,500 $0 -$3,875 -100% 01 Dec 2024 28 Feb 2025 10-Q 24 Apr 2025 2025 Q3
Q4 2024 $11,375 $0 -$3,875 -100% 01 Sep 2024 30 Nov 2024 10-Q 17 Mar 2026 2026 Q2
Q3 2024 $15,250 $3,750 +$3,750 01 Jun 2024 31 Aug 2024 10-Q 17 Nov 2025 2026 Q1
Q2 2024 $11,500 $3,750 +$3,750 01 Mar 2024 31 May 2024 10-K 17 Oct 2025 2025 FY
Q1 2024 $7,750 $3,875 +$3,875 01 Dec 2023 29 Feb 2024 10-Q 24 Apr 2025 2025 Q3
Q4 2023 $3,875 $3,875 +$3,875 01 Sep 2023 30 Nov 2023 10-Q 10 Jan 2025 2025 Q2
Q3 2023 $0 $0 $0 01 Jun 2023 31 Aug 2023 10-Q 11 Oct 2024 2025 Q1
Q2 2023 $0 $0 $0 01 Mar 2023 31 May 2023 10-K 30 Aug 2024 2024 FY
Q1 2023 $0 $0 01 Dec 2022 28 Feb 2023 10-Q 15 Apr 2024 2024 Q3
Q4 2022 $0 01 Sep 2022 30 Nov 2022 10-Q 16 Jan 2024 2024 Q2
Q3 2022 $0 01 Jun 2022 31 Aug 2022 10-Q 11 Oct 2023 2024 Q1
Q2 2022 $0 01 Feb 2022 31 May 2022 10-K 01 Sep 2023 2023 FY

Exousia Bio, Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,750 -$7,750 -67% 01 Jun 2024 31 May 2025 10-K 17 Oct 2025 2025 FY
2023 $11,500 +$11,500 01 Jun 2023 31 May 2024 10-K 17 Oct 2025 2025 FY
2022 $0 01 Jun 2022 31 May 2023 10-K 30 Aug 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.